Health care stocks were higher Monday afternoon, with the NYSE Health Care Index rising 1.4% and the Health Care Select Sector SPDR Fund (XLV) up 1.3%.
The iShares Biotechnology ETF (IBB) added 1.3%.
In corporate news, AstraZeneca (AZN) on Monday agreed to buy Belgian biotech company EsoBiotec in a deal worth up to $1 billion as it looks to boost its cell therapies portfolio. AstraZeneca shares were 0.1% higher.
Hyperfine (HYPR) shares surged 35% after the company said Monday it is collaborating with Nvidia (NVDA) to enhance its portable imaging technology.
Fortress Biotech (FBIO) shares popped 4.8%. The company and Partex said Monday that they're collaborating to identify and evaluate biopharmaceutical compounds using AI for potential acquisition or licensing by Fortress.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。